The changes of immune function after neuroblastoma chemotherapy and the prediction of potential immune targets
Abstract Background High-dose chemotherapy for neuroblastoma is often intolerable for children, and its effectiveness is difficult to determine. Immunotherapy has become a popular research focus as a potential treatment. Therefore, identifying effective immune targets and drug synergistic chemothera...
Saved in:
| Main Authors: | Yunfei Ma, Yan Su, Jing Huang, Wen Zhao, Cheng Huang, Jing Qin, Shengjie You, Yan Hu, Xin Ni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Medical Genomics |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12920-025-02185-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
by: Anders Valind, et al.
Published: (2023-12-01) -
Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma
by: Zan Liu, et al.
Published: (2025-02-01) -
Proximity Proteomics Reveals USP44 Forms a Complex with BRCA2 in Neuroblastoma Cells and Is Required to Prevent Chromosome Breakage
by: Asma Ali, et al.
Published: (2024-12-01) -
From Local to International Approach: Prognostic Factors and Treatment Outcomes in Neuroblastoma—A 30-Year Single-Center Retrospective Analysis
by: Joanna Stankiewicz, et al.
Published: (2025-04-01) -
Metronomic chemotherapy in pediatric neuroblastoma
by: Yi Jiang, et al.
Published: (2024-12-01)